Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S studyHenriette Farkas, William Sheridan, Miloš Jeseňák et al.|Clinical and Translational Allergy|2021Cited by 54
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 yearsJolanta Bernatoniene, Emel Aygören‐Pürsün, M. Bourgoin‐Heck et al.|Annals of Allergy Asthma & Immunology|2025Cited by 5